ENCOMPASS HEALTH REHABILITATION HOSP — History
CCN 103038 | 3-year financial timeline | COVID resilience: 72/100
🛡️ Public data only — no PHI permitted on this instance.
$27M
Latest Revenue (FY2022)
+10.5%
Revenue CAGR (3yr)
12.7%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $22M | $25M | $27M | +5.5% | +10.5% |
| Operating Expenses | $20M | $22M | $23M | +7.8% | +7.6% |
| Operating Margin | 7.9% | 14.6% | 12.7% | -12.9% | +26.5% |
| Net Income | $2M | $4M | $3M | -8.1% | +39.7% |
| Licensed Beds | 60 | 60 | 60 | +0.0% | +0.0% |
| Total Patient Days | 14,455 | 15,626 | 16,597 | +6.2% | +7.2% |
| Medicare Day % | 61% | 56% | 59% | +5.2% | -1.2% |
| Medicaid Day % | 1% | 1% | 1% | +57.5% | +16.7% |
COVID Impact & Recovery
Resilience Score: 72/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +22.0% ($22M → $27M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+10.5%
This Hospital
+7.6%
State Avg
Latest Margin
12.7%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $29M | 15.1% |
| FY2024 (proj) | $31M | 17.4% |
| FY2025 (proj) | $34M | 19.8% |